Publications by authors named "Julia R White"

28Publications

SCHEDULING DELAYED TREATMENT AND SURGERIES POST-PANDEMIC: A STAKEHOLDER ANALYSIS.

Proc Int Symp Hum Factors Ergon Healthc 2020 Sep 16;9(1):10-14. Epub 2020 Sep 16.

Department of Medical Oncology, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2327857920091066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556695PMC
September 2020

Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.

Int J Radiat Oncol Biol Phys 2020 Jul 22. Epub 2020 Jul 22.

Department of Radiation Oncology, The Arthur G. James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2020.07.027DOI Listing
July 2020

Assessing the Impact of CALGB 9343 on Surgical Trends in Elderly-Women With Stage I ER+ Breast Cancer: A SEER-Based Analysis.

Front Oncol 2019 9;9:621. Epub 2019 Jul 9.

Department of Radiation Oncology, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629892PMC
July 2019

Better Just Treat.

Int J Radiat Oncol Biol Phys 2019 02;103(2):295

Department of Radiation Oncology, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.03.020DOI Listing
February 2019

ASO Author Reflections: Shifting the Focus of pT1-2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?

Ann Surg Oncol 2018 12 30;25(Suppl 3):681-682. Epub 2018 Oct 30.

Department of Radiation Oncology, James Cancer Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-018-6986-4
Publisher Site
http://dx.doi.org/10.1245/s10434-018-6986-4DOI Listing
December 2018

Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates.

Ann Surg Oncol 2018 Aug 18;25(8):2288-2295. Epub 2018 Jun 18.

Departments of Radiation Oncology, James Cancer Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6565-8DOI Listing
August 2018

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

J Clin Oncol 2018 06 13;36(16):1611-1618. Epub 2018 Feb 13.

Jason J. Luke, Jeffrey M. Lemons, Theodore G. Karrison, Sean P. Pitroda, James M. Melotek, Yuanyuan Zha, Hania A. Al-Hallaq, Ainhoa Arina, Nikolai N. Khodarev, Linda Janisch, Paul Chang, Jyoti D. Patel, Gini F. Fleming, John Moroney, Manish R. Sharma, Mark J. Ratain, Thomas F. Gajewski, Ralph R. Weichselbaum, and Steven J. Chmura, The University of Chicago, Chicago, IL; Julia R. White, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978468PMC
June 2018

The Role of Postmastectomy Radiation Therapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy.

Semin Radiat Oncol 2016 Jan 29;26(1):51-8. Epub 2015 Aug 29.

Department of Radiation Oncology, The Ohio State University, Columbus, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2015.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718394PMC
January 2016

Regional Nodal Irradiation in Early-Stage Breast Cancer.

N Engl J Med 2015 Jul;373(4):307-16

From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1415340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556358PMC
July 2015

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

J Natl Cancer Inst 2014 Dec 7;106(12). Epub 2014 Nov 7.

Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357796PMC
December 2014

Accelerated fractionation with a concurrent boost for early stage breast cancer.

Radiother Oncol 2013 Jan 17;106(1):15-20. Epub 2013 Jan 17.

University of Pennsylvania, Philadelphia, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2012.12.001DOI Listing
January 2013

Intensity-modulated radiotherapy for breast cancer: advances in whole and partial breast treatment.

Front Radiat Ther Oncol 2011 20;43:292-314. Epub 2011 May 20.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/322461
Publisher Site
http://dx.doi.org/10.1159/000322461DOI Listing
September 2011

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.

Breast Cancer Res Treat 2010 Apr 19;120(2):273-84. Epub 2009 Dec 19.

Montefiore Medical Center - Weiler Division, Professor of Medicine and Women's Health, Albert Einstein College of Medicine, 1825 Eastchester Road, 10461, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0655-zDOI Listing
April 2010

Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.

J Am Coll Radiol 2009 Jun;6(6):442-7

Quality Research in Radiation Oncology, American College of Radiology, 1818 Market Street, Philadelphia, PA 19103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2008.11.008DOI Listing
June 2009

American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma.

J Am Coll Radiol 2008 Jun;5(6):701-13

Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226-4801 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2008.02.026DOI Listing
June 2008

A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial.

Clin Breast Cancer 2003 Dec;4(5):361-3

Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cbc.2003.n.042DOI Listing
December 2003